N4BP1 acts as a nuclear ribonuclease to take charge of keratinocytes and neutrophils, and its abnormality contributes to psoriasis development, presenting it as a potential therapeutic target to treat psoriasis. This evidence concerns the gene N4BP1 and psoriasis.